SCHEMBL1640979

SCHEMBL1640979

Cc1cc(CN2CCC(n3cnc(-c4ccc(F)cc4)c3-c3ccnc(N)n3)C2)no1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 4/20 0.70
CSNK1E P49674 3/20 0.70
MAPK14 Q16539 16/20 0.63
MAPK13 O15264 2/20 0.58
MAPK12 P53778 2/20 0.58
MAPK11 Q15759 2/20 0.58
EGFR P00533 2/20 0.58
KCNH2 Q12809 1/20 0.58
RIPK2 O43353 1/20 0.56
DYRK3 O43781 1/20 0.56
PRKD3 O94806 1/20 0.56
MAP4K4 O95819 1/20 0.56
PRKCG P05129 1/20 0.56
LCK P06239 1/20 0.56
LYN P07948 1/20 0.56
RET P07949 1/20 0.56
PIM1 P11309 1/20 0.56
PRKACA P17612 1/20 0.56
MAPK1 P28482 1/20 0.56
FLT4 P35916 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1641013 0.95 CSNK1D (0.77) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1639870 0.91 CSNK1D (0.68) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1639293 0.88 CSNK1D (0.90) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1640185 0.87 CSNK1D (0.52) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL15203568 0.86 CSNK1D (0.66) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1640846 0.86 MAPK14 (0.67) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1640778 0.85 CSNK1D (0.65) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1639202 0.85 MAPK14 (0.72) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1639753 0.84 CSNK1D (0.67) CSNK1DCSNK1EMAPK14MAPK13MAPK12
SCHEMBL1641017 0.83 MAPK14 (0.62) CSNK1DCSNK1EMAPK14MAPK13MAPK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102686580-B imidazole derivatives as casein kinase inhibitors PFIZER 2014-09-10 CN claimed
EP-2493876-B1 IMIDAZOLE DERIVATIVES AS CASEIN KINASE INHIBITORS PFIZER (US) 2014-02-12 EP disclosed
US-8518944-B2 Compounds as casein kinase inhibitors PFIZER INC. (US) 2013-08-27 US disclosed
US-20110098272-A1 Novel Compounds As Casein Kinase Inhibitors PFIZER INC 2011-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098272-A1 Novel Compounds As Casein Kinase Inhibitors CSNK1A1, CSNK1A1L, CSNK1G1 CSNK1D 12/4885CSNK1E 5/4885MAPK14 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.